Search research articles
Contact Us
Filters
Showing results (11-20 of 253) with videos related to
Page
of 26
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 22, 2009
Use of apomorphine in Parkinson's disease
Fabrizio Stocchi
The Lancet. Neurology
|
June 28, 2015
Neuroprotection in Parkinson's disease: a difficult challenge
Fabrizio Stocchi
Parkinsonism & Related Disorders
|
January 20, 2010
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease
Fabrizio Stocchi
Expert Review of Neurotherapeutics
|
October 9, 2009
Managing the critical problems of advanced Parkinson's disease
Fabrizio Stocchi
Clinical Neuropharmacology
|
April 24, 2010
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio)
Fabrizio Stocchi, Stefano Marconi
Drug Design, Development and Therapy
|
February 27, 2016
Adjuvant therapies for Parkinson's disease: critical evaluation of safinamide
Fabrizio Stocchi, Margherita Torti
Minerva Medica
|
January 23, 2020
A systematic review on the clinical experience with melevodopa/carbidopa fixed combination in patients with Parkinson disease
Fabrizio Stocchi, Laura Vacca
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 4, 2014
The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: implications of continuous dopaminergic stimulation at night to treat the symptoms
Fabrizio Stocchi, Paola Stirpe
International Review of Neurobiology
|
August 15, 2017
Constipation in Parkinson's Disease
Fabrizio Stocchi, Margherita Torti
Neurology
|
January 14, 2004
Continuous dopaminergic stimulation in early and advanced Parkinson's disease
Fabrizio Stocchi, C Warren Olanow
Page
of 26
Search research articles
Search
Showing results (11-20 of 253) with videos related to
Sort By:
Page
of 26
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 22, 2009
Use of apomorphine in Parkinson's disease
Fabrizio Stocchi
The Lancet. Neurology
|
June 28, 2015
Neuroprotection in Parkinson's disease: a difficult challenge
Fabrizio Stocchi
Parkinsonism & Related Disorders
|
January 20, 2010
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease
Fabrizio Stocchi
Expert Review of Neurotherapeutics
|
October 9, 2009
Managing the critical problems of advanced Parkinson's disease
Fabrizio Stocchi
Clinical Neuropharmacology
|
April 24, 2010
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio)
Fabrizio Stocchi, Stefano Marconi
Drug Design, Development and Therapy
|
February 27, 2016
Adjuvant therapies for Parkinson's disease: critical evaluation of safinamide
Fabrizio Stocchi, Margherita Torti
Minerva Medica
|
January 23, 2020
A systematic review on the clinical experience with melevodopa/carbidopa fixed combination in patients with Parkinson disease
Fabrizio Stocchi, Laura Vacca
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 4, 2014
The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: implications of continuous dopaminergic stimulation at night to treat the symptoms
Fabrizio Stocchi, Paola Stirpe
International Review of Neurobiology
|
August 15, 2017
Constipation in Parkinson's Disease
Fabrizio Stocchi, Margherita Torti
Neurology
|
January 14, 2004
Continuous dopaminergic stimulation in early and advanced Parkinson's disease
Fabrizio Stocchi, C Warren Olanow
Page
of 26